Modulatory Effects of Ketamine and Lamotrigine on Cognition: Emotion Interaction in the Brain
Neuropsychobiology · 2023 · 82 (2) · 91-103
DOI: 10.1159/000528315 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Neuropsychobiology, online erschienen am 02.02.2023. Verfasst von Matti Gärtner und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical School Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Ketamine. Die Arbeit wurde bisher 9-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
Cognition and emotion are fundamentally integrated in the brain and mutually contribute to behavior. The relation between working memory (WM) and emotion is particularly suited to investigate cognition-emotion interaction since WM is an essential component of many higher cognitive functions. Ketamine affects not only WM but also has a profound impact on emotional processing. Effects of acute ketamine challenge are sensitive to modulation by pretreatment with lamotrigine, which inhibits glutamate release. Accordingly, a combination of these approaches should be particularly suited to investigate cognition-emotion interaction.
Methods
Seventy five healthy subjects were investigated in a double-blind, placebo-controlled, randomized, single-dose, parallel-group study with three treatment conditions. All subjects underwent two scanning sessions (acute/post 24 h).
Results
Compared to placebo, acute ketamine administration induced significant dissociative, psychotomimetic, and cognitive effects, as well as an increase in neural activity during WM for positive stimuli. Inhibition of glutamate release by pretreatment with lamotrigine did not influence ketamine’s subjective effects, but significantly attenuated its impact on emotional WM and associated neural activity. There was no effect on these measures 24 h after ketamine administration.
Conclusion
Our results demonstrate differential acute effects of modulated glutamate release and a swift restoration of disturbed neurobehavioral homeostasis in healthy subjects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical School Berlin, Berlin, Germany.
- Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.
- Charité Research Organisation GmbH, Berlin, Germany.
- Medical School Berlin, Berlin, Germany, luisa.carstens@medicalschool-berlin.de.
- SBGneuro Ltd., Oxford, UK.
- Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
Zitieren
APA
Gärtner, M., Weigand, A., Keicher, C., Meiering, M. S., Weigner, D., Carstens, L., Hertrampf, R., Beckmann, C., Mennes, M., Wunder, A., & Grimm, S. (2023). Modulatory Effects of Ketamine and Lamotrigine on Cognition: Emotion Interaction in the Brain. Neuropsychobiology, 82(2), 91-103. https://doi.org/10.1159/000528315
Vancouver
Gärtner M, Weigand A, Keicher C, Meiering MS, Weigner D, Carstens L, et al. Modulatory Effects of Ketamine and Lamotrigine on Cognition: Emotion Interaction in the Brain. Neuropsychobiology. 2023;82(2):91-103. doi:10.1159/000528315
BibTeX
@article{Grtner2023,
author = {Gärtner, Matti and Weigand, Anne and Keicher, Christian and Meiering, Marvin Sören and Weigner, David and Carstens, Luisa and Hertrampf, Rita and Beckmann, Christian and Mennes, Maarten and Wunder, Andreas and Grimm, Simone},
title = {Modulatory Effects of Ketamine and Lamotrigine on Cognition: Emotion Interaction in the Brain},
journal = {Neuropsychobiology},
year = {2023},
volume = {82},
number = {2},
pages = {91--103},
doi = {10.1159/000528315}
}
EUVIMED